Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 01, 2018 07:00 ET | Source: Qu Biologics, Inc.

Researchers discover that activating innate immunity in the gastrointestinal tract reduces disease pathology in ulcerative colitis

VANCOUVER, British Columbia, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Qu Biologics Inc. (Qu), a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of...
April 18, 2018 16:16 ET | Source: Qu Biologics

Qu Biologics Begins Phase 2 Clinical Trial in Crohn’s Disease

VANCOUVER, British Columbia, April 18, 2018 (GLOBE NEWSWIRE) -- Qu Biologics Inc. (Qu), a Vancouver, Canada-based biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique...
October 03, 2017 12:16 ET | Source: Qu Biologics

Response to Novel Immune Therapy for Ulcerative Colitis Associated with Genetic and Immune Biomarkers

VANCOUVER, British Columbia , Oct. 03, 2017 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of immunotherapies...